Skip to main content
Hallam Gugelmann, MD, Emergency Medicine, San Francisco, CA

HallamMelvilleGugelmannMD

Emergency Medicine San Francisco, CA

Medical Toxicology, Clinical Pharmacology

Drug developer, emergency medicine physician, medical toxicologist

Dr. Gugelmann is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Gugelmann's full profile

Already have an account?

  • Office

    Basel, Switzerland
    San Francisco, CA 94112

Summary

  • Dr. Hallam Gugelmann is a medical toxicologist and senior medical director in drug development living in Basel Switzerland.

Education & Training

  • University of California (San Francisco)
    University of California (San Francisco)Fellowship, Medical Toxicology (Emergency Medicine), 2013 - 2015
  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemResidency, Emergency Medicine, 2009 - 2013
  • University of North Carolina at Chapel Hill School of Medicine
    University of North Carolina at Chapel Hill School of MedicineClass of 2009
  • University of North Carolina
    University of North CarolinaMPH, 2007 - 2008
  • Johns Hopkins University
    Johns Hopkins UniversityBA, English, 1998 - 2001

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2013 - 2026
  • PA State Medical License
    PA State Medical License 2009 - 2014
  • American Board of Emergency Medicine Emergency Medicine
  • American Board of Emergency Medicine Medical Toxicology

Awards, Honors, & Recognition

  • Fellow of the American College of Emergency Physicians 2018
  • CPC Semi-Finalist SAEM, 2011
  • Frank Porter Graham Graduate and Professional Student Honor Society 2009
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Butanediol Conversion to Gamma‐Hydroxybutyrate Markedly Reduced by the Alcohol Dehydrogenase Blocker Fomepizole  
    Neal L Benowitz, Hallam Gugelmann, Delia A Dempsey, Clinical Pharmacology & Therapeutics
  • Racial disparities across provider specialties in opioid prescriptions dispensed to medicaid beneficiaries with chronic noncancer pain  
    Ringwalt C, Roberts AW, Gugelmann H, Skinner AC, Pain Med., 1/1/2015
  • Young Woman With Seizures  
    Li K, Gugelmann H, Tabas JA., Ann Emerg Med., 1/1/2015
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Lectures

  • Naloxone: The Fundamentals for Pharmacists involved in Dispensing to Caregivers and Patients at risk for Opiate and Opioid Overdose and Toxicity. 
    1/1/2015
  • Ease of Identifying and Purchasing Popular �Research Chemicals� via the Internet 
    1/1/2015
  • Change in Provider Perspectives About Opioid Analgesics Following a Multidisciplinary Educational Intervention to Enhance Safe Opioid Use 
    1/1/2015
  • Join now to see all

Other

  • �Crazy Monkey� synthetic cannabinoid ingestion 
    CBS Online interview and article
    http://tinyurl.com/lub78xp
    1/29/2014
  • Prescription opioid epidemic 
    KQED Radio broadcast
    1/29/2014

Press Mentions

  • Price of Drug That Saves Overdose Victims Soaring Out of Reach
    Price of Drug That Saves Overdose Victims Soaring Out of ReachFebruary 16th, 2017